Presentation is loading. Please wait.

Presentation is loading. Please wait.

1 Single and Dual Chamber Pacemaker Timing Module 6.

Similar presentations


Presentation on theme: "1 Single and Dual Chamber Pacemaker Timing Module 6."— Presentation transcript:

1 1 Single and Dual Chamber Pacemaker Timing Module 6

2 2 Objectives Identify VVI, AAI, DDI, and DDD pacing on an ECG strip Identify basic dual chamber timing concepts –Rate intervals –Inhibition –Triggering Complete a simple VVI and DDD timing diagram –Demonstrating rate calculation –Demonstrating inhibition –Demonstrating magnet application

3 3 Pacemaker Mode Defines the chambers that are paced/sensed Defines how the pacemaker will respond to intrinsic events Defines if rate modulation is available (i.e., DDDR)

4 NBG Code IIIIIIIVV Chamber(s) Paced Chamber(s) Sensed Response to Sensing Rate Modulation Multisite Pacing O = None A = Atrium V = Ventricle D = Dual (A + V) S = Single (A or V) O = None A = Atrium V = Ventricle D = Dual (A + V) S = Single (A or V) O = None T = Triggered I = Inhibited D = Dual (T + I) O = None R = Rate modulation O = None A = Atrium V = Ventricle D = Dual (A + V)

5 NBG Code – The Usual Pacing Modes IIIIIIIVV Chamber(s) Paced Chamber(s) Sensed Response to Sensing Rate Modulation Multisite Pacing O = None A = Atrium V = Ventricle D = Dual (A + V) S = Single (A or V) O = None A = Atrium V = Ventricle D = Dual (A + V) S = Single (A or V) O = None T = Triggered I = Inhibited D = Dual (T + I) O = None R = Rate modulation O = None A = Atrium V = Ventricle D = Dual (A + V) Examples –DDD –DDDR –DDIR –VVI –VVIR –AAI

6 6 Rate and Interval Review Calculated on the horizontal axis –At 25 mm/s speed Each small box = 40 ms Each bold box = 200 ms How do you convert intervals to rate? Click for Answer 60,000 / (Interval in ms) = Rate in bpm

7 7 VVI Mode Chamber paced: Ventricle Chamber sensed: Ventricle Response to sensing: Inhibited –A ventricular sense: Inhibits the next scheduled ventricular pace

8 8 VVI Example Chamber paced: Ventricle Chamber sensed: Ventricle Response to sensing: Inhibition –VVI 60 = Lower Rate timer of 1000 ms Pacing every 1 second if not inhibited VPVP VPVP VPVP Lower Rate Timer 1000 ms Lower Rate Timer ….

9 9 VVI Example VVI 60 Chamber paced: Ventricle –VVI 60 = Lower Rate timer of 1000 ms Pacing every 1 second if not inhibited Chamber sensed: Ventricle Response to sensing: Inhibition A ventricular sense interrupts the pacing interval, resets the lower rate timer, and inhibits the next scheduled paced (x) VPVP VSVS VPVP VPVP Lower rate timer 1000 ms x

10 10 VOO Mode VOO 60 Chamber paced: Ventricle Chamber sensed: None Response to sensing: None The intrinsic ventricular event cannot be sensed, and thus, does not interrupt the pacing interval. VOO results in fixed-rate pacing in the ventricle. Placing a magnet over the pacemaker usually results in this behavior at known rates, for example, 85 ppm ms VPVP VPVP VPVP VPVP

11 11 DDD Mode Chamber paced: Atrium & ventricle Chamber sensed: Atrium & ventricle Response to sensing: Triggered & inhibited –An atrial sense: Inhibits the next scheduled atrial pace Re-starts the lower rate timer Triggers an AV interval (called a Sensed AV Interval or SAV) –An atrial pace: Re-starts the lower rate timer Triggers an AV delay timer (the Paced AV or PAV) –A ventricular sense: Inhibits the next scheduled ventricular pace

12 12 DDD Examples The Four Faces of DDD Atrial and ventricular pacing –Atrial pace re-starts the lower rate timer and triggers an AV delay timer (PAV) The PAV expires without being inhibited by a ventricular sense, resulting in a ventricular pace APAP APAP VPVP VPVP

13 13 DDD Examples The Four Faces of DDD Atrial pacing and ventricular sensing –Atrial pace restarts the lower rate timer and triggers an AV delay timer (PAV) Before the PAV can expire, it is inhibited by an intrinsic ventricular event (R-wave) APAP APAP VSVS VSVS

14 14 DDD Examples The Four Faces of DDD Atrial sensing, ventricular pacing –The intrinsic atrial event (P-wave) inhibits the lower rate timer and triggers an AV delay timer (SAV) The SAV expires without being inhibited by an intrinsic ventricular event, resulting in a ventricular pace ASAS ASAS VPVP VPVP

15 15 DDD Examples The Four Faces of DDD Atrial and ventricular sensing –The intrinsic atrial event (P-wave) inhibits the lower rate timer and triggers an AV delay timer (SAV) Before the SAV can expire, it is inhibited by an intrinsic ventricular event (R-wave) ASAS ASAS VSVS VSVS

16 16 Dual Response to Sensing DDD The pacemaker can: –Inhibit and trigger –A P-wave inhibits atrial pacing and triggers an SAV interval –An atrial pace triggers a PAV interval –An R-wave inhibits ventricular pacing Well see later how a PVC can affect atrial timing

17 17 Nuggets Note that in both the single and dual chamber examples: –When the device paces – for the purposes of timing – capture is assumed Some newer devices have algorithms to check for capture –Sensing is critical to timing If the device fails to sense, undersensing, it will usually pace If it oversenses, e.g., senses myopotentials, it will inhibit pacing

18 18 Remember This Strip? Intermittent loss of capture (LOC) –Note how the underlying timing is unaffected by the failure to capture –For timing purposes, pace = capture Review question: Name some possible causes for this condition. Incomplete fracture, insulation failure, lead dislodgement, poor connection in header, programming error, change in pacing thresholds… Click for Answer DDD

19 19 Diagnose This Strip Undersensing, the device fails to reliably see P-waves Because: The atrial lower rate timer is not inhibited – there are atrial pacing spikes The intrinsic P-waves do not start an SAV Click for Answer How do we know this is undersensing? DDD

20 20 DDI Mode Chamber paced: Atrium & ventricle Chamber sensed: Atrium & ventricle Response to sensing: Inhibited –An atrial sense: Inhibits the next scheduled atrial pace Re-starts the lower rate timer –An atrial pace: Re-starts the lower rate timer Starts an AV delay timer (the Paced AV or PAV) –A ventricular sense: Inhibits the next scheduled ventricular pace

21 21 DDI Example Why would we want a dual chamber pacing mode that does not trigger an SAV? Click for Hint What rhythm is this? The underlying rhythm is an atrial tachycardia. PPPPPPP P PPPP

22 22 This function has come to be called Mode Switching DDI – Not tracking the AF Click to change DDI Example Why would we want to use DDI? –To control pacemaker timing during atrial tachycardias Avoids a fast paced ventricular response to AT/AF May limit patient symptoms during AT/AF DDD – tracking the AF 540ms = 110bpm

23 23 Status Check Calculate the atrial rate Measure the P-R interval Measure the QRS duration Click for Answer Atrial Rate: 70 bpm (860 ms) P-R: 120 ms QRS: About 100 ms

24 24 A.DDD – Yes, the intrinsic rate could be faster than the lower rate, and the PAV/SAV is longer than the P-R interval. B.VVI – Yes, the ventricular rate is faster than the lower rate, thus inhibiting the IPG. C.AAI – Yes, the atrial rate is faster than the lower rate, thus inhibiting the IPG. D.DOO – No, DOO results in fixed rate pacing. No sensing is possible, no inhibition is possible. Status Check Which pacemaker modes could be operating on this strip? Assume normal pacemaker operation A. DDD B. VVI C. AAI D. DOO Click for Answer

25 25 Status Check Which pacemaker modes could be operating on this strip? Assume normal pacemaker operation Click for Answer A.DDD B.VVI C.AAI D.DOO A.DDD – Yes, this is very likely the DDD mode. B.VVI – Yes, it could be, but the consistent A-V relationship should make us suspicious. C.AAI – No, not possible. Cannot have ventricular pacing in the AAI mode. D.DOO – No, DOO results in fixed rate pacing. No sensing is possible, no inhibition is possible. We would see atrial and ventricular pacing if this was DOO.

26 26 Status Check Which pacemaker modes could be operating on this strip? Assume normal pacemaker operation Click for Answer A.DDD B.DDI C.VOO D.DOO A.DDD – Yes, this is very likely the DDD mode. This is sometimes called tracking, as the ventricle is tracking the atrium. B.DDI – Not possible. The consistent AV intervals suggest the P-wave is triggering an SAV. DDI inhibits only, triggering not possible. C.VOO – Not likely because of the consistent AV intervals. Unable to diagnose until we see the IPG response to an intrinsic ventricular event (evidence of sensing). D.DOO – No, DOO results in fixed rate pacing. No sensing is possible, no inhibition is possible. We would see atrial and ventricular pacing if this was DOO.

27 27 Brief Statements Indications Implantable Pulse Generators (IPGs) are indicated for rate adaptive pacing in patients who ay benefit from increased pacing rates concurrent with increases in activity and increases in activity and/or minute ventilation. Pacemakers are also indicated for dual chamber and atrial tracking modes in patients who may benefit from maintenance of AV synchrony. Dual chamber modes are specifically indicated for treatment of conduction disorders that require restoration of both rate and AV synchrony, which include various degrees of AV block to maintain the atrial contribution to cardiac output and VVI intolerance (e.g. pacemaker syndrome) in the presence of persistent sinus rhythm. Implantable cardioverter defibrillators (ICDs) are indicated for ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. Cardiac Resynchronization Therapy (CRT) ICDs are indicated for ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias and for the reduction of the symptoms of moderate to severe heart failure (NYHA Functional Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy and have a left ventricular ejection fraction less than or equal to 35% and a QRS duration of 130 ms. CRT IPGs are indicated for the reduction of the symptoms of moderate to severe heart failure (NYHA Functional Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction less than or equal to 35% and a QRS duration of 130 ms. Contraindications IPGs and CRT IPGs are contraindicated for dual chamber atrial pacing in patients with chronic refractory atrial tachyarrhythmias; asynchronous pacing in the presence (or likelihood) of competitive paced and intrinsic rhythms; unipolar pacing for patients with an implanted cardioverter defibrillator because it may cause unwanted delivery or inhibition of ICD therapy; and certain IPGs are contraindicated for use with epicardial leads and with abdominal implantation. ICDs and CRT ICDs are contraindicated in patients whose ventricular tachyarrhythmias may have transient or reversible causes, patients with incessant VT or VF, and for patients who have a unipolar pacemaker. ICDs are also contraindicated for patients whose primary disorder is bradyarrhythmia.

28 28 Brief Statements (continued) Warnings/Precautions Changes in a patients disease and/or medications may alter the efficacy of the devices programmed parameters. Patients should avoid sources of magnetic and electromagnetic radiation to avoid possible underdetection, inappropriate sensing and/or therapy delivery, tissue damage, induction of an arrhythmia, device electrical reset or device damage. Do not place transthoracic defibrillation paddles directly over the device. Additionally, for CRT ICDs and CRT IPGs, certain programming and device operations may not provide cardiac resynchronization. Also for CRT IPGs, Elective Replacement Indicator (ERI) results in the device switching to VVI pacing at 65 ppm. In this mode, patients may experience loss of cardiac resynchronization therapy and / or loss of AV synchrony. For this reason, the device should be replaced prior to ERI being set. Potential complications Potential complications include, but are not limited to, rejection phenomena, erosion through the skin, muscle or nerve stimulation, oversensing, failure to detect and/or terminate arrhythmia episodes, and surgical complications such as hematoma, infection, inflammation, and thrombosis. An additional complication for ICDs and CRT ICDs is the acceleration of ventricular tachycardia. See the device manual for detailed information regarding the implant procedure, indications, contraindications, warnings, precautions, and potential complications/adverse events. For further information, please call Medtronic at and/or consult Medtronics website at Caution: Federal law (USA) restricts these devices to sale by or on the order of a physician.

29 29 Brief Statement: Medtronic Leads Indications Medtronic leads are used as part of a cardiac rhythm disease management system. Leads are intended for pacing and sensing and/or defibrillation. Defibrillation leads have application for patients for whom implantable cardioverter defibrillation is indicated Contraindications Medtronic leads are contraindicated for the following: ventricular use in patients with tricuspid valvular disease or a tricuspid mechanical heart valve. patients for whom a single dose of 1.0 mg of dexamethasone sodium phosphate or dexamethasone acetate may be contraindicated. (includes all leads which contain these steroids) Epicardial leads should not be used on patients with a heavily infracted or fibrotic myocardium. The SelectSecure Model 3830 Lead is also contraindicated for the following: patients for whom a single dose of 40.µg of beclomethasone dipropionate may be contraindicated. patients with obstructed or inadequate vasculature for intravenous catheterization.

30 30 Brief Statement: Medtronic Leads (continued) Warnings/Precautions People with metal implants such as pacemakers, implantable cardioverter defibrillators (ICDs), and accompanying leads should not receive diathermy treatment. The interaction between the implant and diathermy can cause tissue damage, fibrillation, or damage to the device components, which could result in serious injury, loss of therapy, or the need to reprogram or replace the device. For the SelectSecure Model 3830 lead, total patient exposure to beclomethasone 17,21-dipropionate should be considered when implanting multiple leads. No drug interactions with inhaled beclomethasone 17,21-dipropionate have been described. Drug interactions of beclomethasone 17,21-dipropionate with the Model 3830 lead have not been studied. Potential Complications Potential complications include, but are not limited to, valve damage, fibrillation and other arrhythmias, thrombosis, thrombotic and air embolism, cardiac perforation, heart wall rupture, cardiac tamponade, muscle or nerve stimulation, pericardial rub, infection, myocardial irritability, and pneumothorax. Other potential complications related to the lead may include lead dislodgement, lead conductor fracture, insulation failure, threshold elevation or exit block. See specific device manual for detailed information regarding the implant procedure, indications, contraindications, warnings, precautions, and potential complications/adverse events. For further information, please call Medtronic at and/or consult Medtronics website at Caution: Federal law (USA) restricts this device to sale by or on the order of a physician.

31 31 Disclosure NOTE: This presentation is provided for general educational purposes only and should not be considered the exclusive source for this type of information. At all times, it is the professional responsibility of the practitioner to exercise independent clinical judgment in a particular situation. NOTE: This presentation is provided for general educational purposes only and should not be considered the exclusive source for this type of information. At all times, it is the professional responsibility of the practitioner to exercise independent clinical judgment in a particular situation.


Download ppt "1 Single and Dual Chamber Pacemaker Timing Module 6."

Similar presentations


Ads by Google